China Life Insurance Co. (NYSE:LFC) saw unusually-high trading volume on Monday . Approximately 611,418 shares were traded during mid-day trading, a decline of 18% from the previous session’s volume of 743,817 shares.The stock last traded at $11.48 and had previously closed at $11.33.

Separately, Zacks Investment Research lowered China Life Insurance from a “buy” rating to a “hold” rating in a research note on Thursday, June 16th.

The company has a market capitalization of $66.31 billion and a PE ratio of 15.676. The firm’s 50 day moving average price is $10.84 and its 200-day moving average price is $11.56.

Several hedge funds and institutional investors recently bought and sold shares of LFC. Todd Asset Management LLC boosted its position in China Life Insurance by 228.6% in the fourth quarter. Todd Asset Management LLC now owns 488,948 shares of the company’s stock worth $7,818,000 after buying an additional 340,148 shares during the last quarter. First Trust Advisors LP increased its stake in shares of China Life Insurance by 15.4% in the fourth quarter. First Trust Advisors LP now owns 94,021 shares of the company’s stock valued at $1,503,000 after buying an additional 12,578 shares during the period. Comerica Bank increased its stake in shares of China Life Insurance by 4.7% in the fourth quarter. Comerica Bank now owns 80,105 shares of the company’s stock valued at $1,163,000 after buying an additional 3,581 shares during the period. Bank of Montreal Can increased its stake in shares of China Life Insurance by 6.1% in the fourth quarter. Bank of Montreal Can now owns 64,364 shares of the company’s stock valued at $1,029,000 after buying an additional 3,687 shares during the period. Finally, BNP Paribas Arbitrage SA increased its stake in shares of China Life Insurance by 25.0% in the fourth quarter. BNP Paribas Arbitrage SA now owns 91,570 shares of the company’s stock valued at $1,464,000 after buying an additional 18,303 shares during the period.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.